search
Back to results

Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients at Risk for Acute Compartment Syndrome

Primary Purpose

Compartment Syndrome Traumatic Lower Extremity, Compartment Syndrome Traumatic Upper Extremity

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
MY01 Continuous Compartmental Pressure Monitor
Sponsored by
MY01 Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Compartment Syndrome Traumatic Lower Extremity focused on measuring Acute Compartment Syndrome

Eligibility Criteria

16 Years - 65 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults age 16-65.
  • Fracture of the tibia, foot, forearm, femur, or humerus that is felt by the surgeon to have a reasonable indication that elevated intracompartmental pressure could occur in the patient.
  • Planned admission to hospital (to enable monitoring of compartment pressures)
  • Provision of informed consent to participate.

Exclusion Criteria:

  • Frankly contaminated or infected wounds or fractures.
  • Clinical suspicion of acute compartment syndrome requiring urgent fasciotomy at time of presentation to study center.
  • Current or pre-existing neuropathy in the study limb.
  • Pregnant women.

Sites / Locations

  • Foothills Medical CenterRecruiting
  • Halifax InfirmaryRecruiting
  • London Health Sciences CentreRecruiting
  • Ottawa Civic HospitalRecruiting
  • St. Michael's HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

MY01 Device

Arm Description

Device: MY01 Device Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure

Outcomes

Primary Outcome Measures

Clinical ease with which the MY01 device is able to be inserted into a compartment.
At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate on a sliding scale "How certain are you that the sensor is in the correction position?" [1 = uncertain] - [5 = very certain]. The scale, administered part of a Clinical Report Form (CRF) titled 'Physician Survey', measures the physicians subjective level of certainty that the device sensor was inserted correctly within a patients muscle compartment. A record of 5 should be considered a positive scenario, whereas a record of 1 should indicate a negative scenario.
Ability to monitor in real time the continuous pressure readout from the compartment in remote locations via smartphone.
At insertion of device the physician will complete a feedback questionnaire on the device, the participant will be assessed for adverse events, and routine assessment will be performed.
The change in intracompartmental pressure.
Routine assessments will be completed by healthcare personnel as per standard of care (the 6P's [Pain, Paraesthesia, Pallor, Paralysis, Pulselessness, Poikilothermia]), and compared against the pressure readout [mmHG] indicated by MY01's MicroElectroMechanical (MEMS) pressure sensor inserted at the afflicted location.

Secondary Outcome Measures

Adverse events associated with the use of the device.
The patient will be monitored for adverse events during treatment, and will be reassessed during the final follow-up of the participant at the first return visit to the fracture clinic. An adverse event constitutes "Any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal lab findings) in participants, users or other persons, whether or not related to the investigational device."
Pain at insertion site.
Participants will be asked to keep a diary while the device is in situ. The diary will consist of a pain Visual Analog Score (VAS) to be completed each time their vitals are taken, with space to freely comment on the device. VAS will be on a sliding scale where [0=no pain] and [10=pain as bad as it can be].

Full Information

First Posted
July 3, 2019
Last Updated
May 31, 2022
Sponsor
MY01 Inc.
Collaborators
Nova Scotia Health Authority
search

1. Study Identification

Unique Protocol Identification Number
NCT04012723
Brief Title
Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients at Risk for Acute Compartment Syndrome
Official Title
Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients With an Upper or Lower Extremity Fracture at Risk for Acute Compartment Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 17, 2020 (Actual)
Primary Completion Date
June 2022 (Anticipated)
Study Completion Date
July 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
MY01 Inc.
Collaborators
Nova Scotia Health Authority

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Compartment syndrome remains a very serious complication of lower extremity trauma and/or procedural cases that involved lower or upper extremity surgery. This condition results in muscle death, chronic pain, infection, and possible amputation. Early diagnosis is essential to institute interventions to avoid complications. Unfortunately, the subjective pain of the patient remains the mainstay for diagnosis. A method or device is needed that would improve the investigator's ability to diagnose this potentially devastating condition. The purpose of this trial is to evaluate the safety and functionality of MY01, an investigational device that allows continuous monitoring of intracompartmental muscle pressure in patients at risk for developing acute compartment syndrome. This is a single centre, non-randomized, non-controlled, unblinded, prospective trial of the MY01 device. A cohort of 25 participants will be prospectively enrolled to document the performance of the device.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Compartment Syndrome Traumatic Lower Extremity, Compartment Syndrome Traumatic Upper Extremity
Keywords
Acute Compartment Syndrome

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
25 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
MY01 Device
Arm Type
Experimental
Arm Description
Device: MY01 Device Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure
Intervention Type
Device
Intervention Name(s)
MY01 Continuous Compartmental Pressure Monitor
Intervention Description
The MY01 Continuous Compartmental Pressure Monitor is intended for real-time and continuous measurement of compartmental pressures.
Primary Outcome Measure Information:
Title
Clinical ease with which the MY01 device is able to be inserted into a compartment.
Description
At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate on a sliding scale "How certain are you that the sensor is in the correction position?" [1 = uncertain] - [5 = very certain]. The scale, administered part of a Clinical Report Form (CRF) titled 'Physician Survey', measures the physicians subjective level of certainty that the device sensor was inserted correctly within a patients muscle compartment. A record of 5 should be considered a positive scenario, whereas a record of 1 should indicate a negative scenario.
Time Frame
24-48 hours following device insertion.
Title
Ability to monitor in real time the continuous pressure readout from the compartment in remote locations via smartphone.
Description
At insertion of device the physician will complete a feedback questionnaire on the device, the participant will be assessed for adverse events, and routine assessment will be performed.
Time Frame
24-48 hours following device insertion.
Title
The change in intracompartmental pressure.
Description
Routine assessments will be completed by healthcare personnel as per standard of care (the 6P's [Pain, Paraesthesia, Pallor, Paralysis, Pulselessness, Poikilothermia]), and compared against the pressure readout [mmHG] indicated by MY01's MicroElectroMechanical (MEMS) pressure sensor inserted at the afflicted location.
Time Frame
24-48 hours following device insertion.
Secondary Outcome Measure Information:
Title
Adverse events associated with the use of the device.
Description
The patient will be monitored for adverse events during treatment, and will be reassessed during the final follow-up of the participant at the first return visit to the fracture clinic. An adverse event constitutes "Any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal lab findings) in participants, users or other persons, whether or not related to the investigational device."
Time Frame
24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment.
Title
Pain at insertion site.
Description
Participants will be asked to keep a diary while the device is in situ. The diary will consist of a pain Visual Analog Score (VAS) to be completed each time their vitals are taken, with space to freely comment on the device. VAS will be on a sliding scale where [0=no pain] and [10=pain as bad as it can be].
Time Frame
24-48 hours following device insertion.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults age 16-65. Fracture of the tibia, foot, forearm, femur, or humerus that is felt by the surgeon to have a reasonable indication that elevated intracompartmental pressure could occur in the patient. Planned admission to hospital (to enable monitoring of compartment pressures) Provision of informed consent to participate. Exclusion Criteria: Frankly contaminated or infected wounds or fractures. Clinical suspicion of acute compartment syndrome requiring urgent fasciotomy at time of presentation to study center. Current or pre-existing neuropathy in the study limb. Pregnant women.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Abdelkrim Temzi
Phone
5145616809
Email
abdel.temzi@my01.io
First Name & Middle Initial & Last Name or Official Title & Degree
Kelly Trask
Phone
902-473-3161
Email
kelly.trask@nshealth.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ross Leighton, MD
Organizational Affiliation
Orthopaedic Surgeon, Nova Scotia Health Authority
Official's Role
Principal Investigator
Facility Information:
Facility Name
Foothills Medical Center
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N 2T9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kelcie Witges
First Name & Middle Initial & Last Name & Degree
Prism Schneider, MD
Facility Name
Halifax Infirmary
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 1V7
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kelly Trask
Phone
902-473-3161
Email
kelly.trask@nshealth.ca
First Name & Middle Initial & Last Name & Degree
Shelley MacDonald
Phone
902-473-4098
Email
shelleyl.macdonald@nshealth.ca
First Name & Middle Initial & Last Name & Degree
Ross K Leighton, MD
Facility Name
London Health Sciences Centre
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5W9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Relka Bihari
First Name & Middle Initial & Last Name & Degree
Abdelrahman Lawendy
Facility Name
Ottawa Civic Hospital
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1Y 4E9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melanie Dodd-Moher
First Name & Middle Initial & Last Name & Degree
Allan Liew
Facility Name
St. Michael's Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer Hidy
First Name & Middle Initial & Last Name & Degree
Jeremy Hall

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients at Risk for Acute Compartment Syndrome

We'll reach out to this number within 24 hrs